中国医药

600056.SH

Wind Industry: 医疗保健 > 医疗设备与服务 > 医疗保健提供商与服务 > 保健护理产品经销商

公司是在上海证券交易所挂牌的国有控股上市公司。公司前身为1983年成立的中国医药保健品进出口总公司，1999年加入中国通用技术(集团)控股有限责任公司，现已成为集团旗下集医药工业、医药商业、医疗器械、国际业务、大健康与电商于一体的综合性医药健康产业平台。公司践行“以科技进步和品质服务引领美好生活”的企业使命，以“诚信、包容、创新、实干、卓越、共赢”为核心价值观，立足建设“科、工、贸、技、服”一体化发展的医药及医疗器械健康产业集团目标，强化企业创新主体地位，加快实业化转型步伐，致力于健康中国建设、“一带一路”建设，致力于服务人民美好生活。作为全国重要医药商业流通企业、国家医药储备承储单位、国家医疗物资援外工作执行单位，一路走来，无论是服务国之大者、助力乡村振兴，还是共建“一带一路”、保障人民健康，中国医药收获了一系列庄严的荣誉。面向“十五五”，中国医药将坚持和加强党的领导党的建设，以高质量发展为主题，以科技创新为核心动力，全面深化各业务板块转型升级，强化产业链协同，推动数字化、智能化融合，致力于在2030年成为医药先进制造国内一流领军企业，为保障人民健康、服务国家战略贡献更大力量。

ESG Score Industry Ranking:
9 / 118 (医疗保健提供商与服务)

ESG Rating Distribution(医疗保健提供商与服务)

AAA

2.54%

17.80%

23.73%

BBB

31.36%

17.80%

1.69%

CCC

Trend of Rating

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：7.63Updated on 2026-10-29

07.6310

Management & Practices Score：4.63Updated on 2026-10-15

04.637

Controversies Score：2.99Updated on 2026-10-29

02.993

ESG Score Comparison

Indicator	Company Score	Industry Average	Weight
Environmental	4.83	3.34	5.17%
Social	6.45	3.84	67.23%
Governance	7.38	5.25	27.59%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB

More Details

Peer Comparison(118 companies in the industry) ?

Ranking	Code	Security Name	ESG Rating	ESG Score	Controversies Score	Management & Practices Score	Environmental	Social	Governance
1	300143.SZ	盈康生命	AA	8.89	3.00	5.89	7.09	8.82	7.68
2	2325.HK	云康集团	AA	8.19	2.99	5.19	5.36	7.87	6.73
3	300015.SZ	爱尔眼科	AA	8.17	2.99	5.18	6.28	7.34	7.75
4	9860.HK	艾迪康控股	A	7.97	3.00	4.97	3.99	7.26	7.29
5	000963.SZ	华东医药	A	7.94	3.00	4.94	5.39	7.03	7.45
6	000950.SZ	重药控股	A	7.84	2.99	4.85	5.54	7.03	6.95
7	603882.SH	金域医学	A	7.83	2.94	4.89	4.05	7.26	6.89
8	301103.SZ	何氏眼科	A	7.82	2.98	4.84	4.10	7.35	6.40
9	600056.SH	中国医药	A	7.63	2.99	4.63	4.83	6.45	7.38
10	2666.HK	环球医疗	A	7.61	3.00	4.61	3.78	6.81	6.57